Last reviewed · How we verify
NCT07306455: Jump
Validity of Wearable Sensor for Jump Height
trial testing BTS G-sensor in Healthy Volunteers in 29 participants. Completed in 30 June 2025.
30 June 2025
Quick facts
| Lead sponsor | Busra Kalkan Balak |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 29 |
| Start date | 1 March 2025 |
| Primary completion | 30 June 2025 |
| Estimated completion | 30 June 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- BTS G-sensor
- BTS G-sensor
Conditions studied
- Healthy Volunteers — all drugs for Healthy Volunteers →
- Physical Fitness (G11.427.410.698) — all drugs for Physical Fitness (G11.427.410.698) →
Sponsor
Busra Kalkan Balak
Who can join
Adults 18 to 35, any sex, with Healthy Volunteers or Physical Fitness (G11.427.410.698). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to evaluate the concurrent validity of a wearable motion sensor (BTS G-sensor) in measuring countermovement jump (CMJ) height. Healthy female volunteers between 18 and 35 years of age will perform CMJ tests. Jump height will be measured simultaneously using the BTS G-sensor and the My Jump smartphone application, which has previously demonstrated validity and reliability. The study will assess the level of agreement between the two measurement methods.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07306455
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Healthy Volunteers
Currently open trials in the same condition.
- NCT07504003 — Influence of Training Session Duration on Improvements in Physiological Resilience to Exercise · NA · recruiting
- NCT07446400 — A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuva · Phase 1 · recruiting
- NCT07495813 — A Study to See How RO7763505 Works and How Safe it is When Given to Healthy People and People With Stable Heart Disease · Phase 1 · recruiting
- NCT07499050 — A Study of Multiple Doses of Orally Administered RO7795081 in Otherwise Healthy Chinese Adult Participants With Obesity · Phase 1 · recruiting
- NCT07342114 — A Dose-Escalation Study of RO7875913 in Healthy Participants · Phase 1 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07306455 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Busra Kalkan Balak
- Last refreshed: 29 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07306455.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing